What is the main business of Zakład Farmaceutyczny Amara?

The main business activity of Zakład Farmaceutyczny Amara focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 7, 2001.

Where is the headquarters located?

The headquarters is located at: Stacyjna 5, 30-851 Kraków.

Who is on the management board?

The management board consists of: Magdalena Bogucka (President of the Management Board) and Paweł Staniewski (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 2,000,000 (approx. $540,249).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $47,274,878 in 2025, which is an increase of 92.4% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $6,942,639, meaning the company increased its profit by 299.4%.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $5,408,054 in 2025, representing 25% of all operating expenses.

Zakład Farmaceutyczny Amarasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2001-06-07

Share capital

2 000 000,00 PLN

Registered address

Stacyjna 5, 30-851 Kraków, Poland

Electronic delivery address

AE:PL-54132-70970-WSIDB-21

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 47.27mMedianUSD 782.27kAverageUSD 24.03m

Net profit

This companyUSD 6.94mMedianUSD 7.91kAverageUSD 2.59m

Operating costs

This companyUSD 21.59mMedianUSD 723.93kAverageUSD 19.92m

Assets

This companyUSD 33.44mMedianUSD 800.34kAverageUSD 29.11m

Industry

Bank accounts

Registered as a VAT taxpayer on 2001-06-29. Active

PKO Bank Polski
39 1020 2892 0000 5002 0920 0397
BNP Paribas Bank Polska
87 1750 1048 0000 0000 1198 9756
ING Bank Śląski
77 1050 1445 1000 0090 3027 5060

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$213.9K$213,941
Buildings and premises	$7.3M$7,287,438

Properties named as collateral

Nieruchomość

Secured liabilities

Type	Creditor
Mortgage	–
Assignment of receivables	–
Mortgage	–

Public aid

9 public aid cases recorded, with a total value of $157,182.

Grant date	Purpose	Gross amount	Granting body
Mar 26, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$52,607$52,607	Prezydent Miasta Kraków
Apr 30, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$14,291$14,291	MAŁOPOLSKI URZĄD SKARBOWY W KRAKOWIE
Oct 25, 2024	De minimis aid (in accordance with Commission Regulation 2023/2831)	$1,851$1,851	MAŁOPOLSKI URZĄD SKARBOWY W KRAKOWIE

Tenders

No recorded participation in tenders.

Trademarks

Zakład Farmaceutyczny Amara holds 86 active trademarks registered with the Polish Patent Office. 20 marks have expired or were not registered. The first mark was filed in 1994.

Mark	Number	Classes	Status	Protected until
AMADERM PSORIA(word)	Z.578947	3, 5, 10, 35	Protected	Jan 9, 2035
AMADERM baby(word)	Z.578949	3, 5, 10, 35	Protected	Jan 9, 2035
AMADERM ONCO(word)	Z.578948	3, 5, 10, 35	Protected	Jan 9, 2035
AMADERM HYDRA(word)	Z.577593	3, 5, 10, 35	Protected	Dec 2, 2034
ECOMER BABY DHA(word)	Z.577583	5	Protected	Dec 2, 2034

Mark	Protected until
AMADERM PSORIA(word)	Jan 9, 2035
AMADERM baby(word)	Jan 9, 2035
AMADERM ONCO(word)	Jan 9, 2035
AMADERM HYDRA(word)	Dec 2, 2034
ECOMER BABY DHA(word)	Dec 2, 2034

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Magdalena Bogucka – President of the Management Board

Paweł Staniewski – Management Board Member

Manner of representation

To submit declarations of will on behalf of the company, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required.

Supervisory board

Bartłomiej Stanisław Bogucki – Supervisory Board Member

Jakub Maksymilian Bogucki – Supervisory Board Member

Jarosław Jan Bogucki – Supervisory Board Member

Bronisław Józef Wycisk – Supervisory Board Member

Rafał Sonik – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Amara sp. z o.o.	1,440	$194,489.47	36%
Bartłomiej Stanisław Bogucki (42)	400	$54,024.85	10%
Jakub Maksymilian Bogucki (38)	400	$54,024.85	10%
Jarosław Jan Bogucki (67)	800	$108,049.70	20%
Gemini Holding sp. z o.o.	960	$129,659.64	24%

Beneficial owners

Person	Rights

Subsidiaries

Name	Share value	Stake
Amadermsp. z o.o.	1,350.62 USD	100%
Mikrografiasp. z o.o.	13,506.21 USD	100%
Amara Active Healingsp. z o.o.	4,997.30 USD	100%

Competitors

Name	Revenue	Website
Celon PharmaS.A.	$52,550,739.16	celonpharma.com
Wrocławskie Zakłady Zielarskie HerbapolS.A.	$46,537,868.51	herbapol.pl
Phytopharm KlękaS.A.	$46,154,888.31	phytopharm.pl
VercoS.A.	$43,577,172.02	verco.com.pl
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.	$37,103,878.54	biomed.pl
Poznańskie Zakłady Zielarskie HerbapolS.A.	$31,668,225.77	herbapol.poznan.pl
Fagronsp. z o.o.	$21,715,187.73	fagron.pl
Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A.	$7,294,338.51	herbapol.krakow.pl
F1 PharmaS.A.	$272,113.66	f1pharma.pl
Zakład Farmaceutyczny Amarasp. j.	$0.00	amara.pl

Change history

Date	Event
2021-03-18	Share capital change (800,000.00 PLN → 2,000,000.00 PLN)
2011-01-18	Share capital change (500,000.00 PLN → 800,000.00 PLN)
2006-01-16	Share capital change (62,500.00 PLN → 500,000.00 PLN)
2004-02-25	Share capital change (50,000.00 PLN → 62,500.00 PLN)
2001-06-07	Entered in the register

FAQ

Last updated: 2026-06-10